OAKLAND, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Omicia, Inc., has announced a partnership with the University of Utah’s Utah Genome Project. Under a two-year licensing agreement with Omicia, the University will use and advance Opal, the company’s whole genome analysis platform for research and clinical applications. The agreement enables the University’s researchers and clinicians to use Opal on a cost-per-genome basis. Through the partnership, all researchers and clinicians at the University of Utah will have access to the Opal platform.
Help employers find you! Check out all the jobs and post your resume.
